Patent assignee · US · COMPANY

NEXALIN TECHNOLOGY, INC.

🏢 View company profile →
6Patents
6Active
6Granted
57Portfolio score

Filing activity: Dec 9, 2020 → Mar 19, 2025

Most-cited patents

PatentTitleAreaCited byStatus
USD1073092S1 Transcranial electro-stimulation device General 1 Active
US12263336B2 Alternating current dynamic frequency stimulation system and method for opioid use disorder (OUD) and substance use disorder (SUD) Human Necessities 0 Active
US11872397B2 Transcranial alternating current dynamic frequency stimulation (TACS) system Human Necessities 0 Active
US12011591B2 Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and dementia Human Necessities 0 Active
USD1092758S1 Transcranial electro-stimulation device General 0 Active
US11944806B2 Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (ADI) Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.